See more : Dubai Financial Market P.J.S.C. (DFM.AE) Income Statement Analysis – Financial Results
Complete financial analysis of 1933 Industries Inc. (TGIFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 1933 Industries Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Test Research, Inc. (3030.TW) Income Statement Analysis – Financial Results
- Westshore Terminals Investment Corporation (WTE.TO) Income Statement Analysis – Financial Results
- Pulmuone Co., Ltd. (017810.KS) Income Statement Analysis – Financial Results
- PT Medco Energi Internasional Tbk (MEYYY) Income Statement Analysis – Financial Results
- Zensun Enterprises Limited (0185.HK) Income Statement Analysis – Financial Results
1933 Industries Inc. (TGIFF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.1933industries.com
About 1933 Industries Inc.
1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in the medical and recreational cannabis sectors. The company also offers cannabidiol (CBD) infused products, such as vape pens, cartridges, lotions, lip balms, hemp seed oils, edible products, topical and dietary supplements, cosmetics, tinctures, sauces, vaporizers, drink additives, baking items, sweeteners, capsules, and tetrahydrocannabinol concentrates under the Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused brands. In addition, it provides cannabis flowers and concentrates. 1933 Industries Inc. offers CBD infused products through retail dispensaries, retail outlets, and e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. The company is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.27M | 12.54M | 11.98M | 11.96M | 18.06M | 12.65M | 1.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.00 | 409.00 | 2.66K |
| Cost of Revenue | 22.50M | 9.85M | 7.16M | 9.68M | 12.76M | 6.20M | 799.58K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -4.22M | 2.69M | 4.82M | 2.28M | 5.30M | 6.45M | 230.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.00 | 409.00 | 2.66K |
| Gross Profit Ratio | -23.12% | 21.46% | 40.25% | 19.10% | 29.33% | 50.99% | 22.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.02M | 6.63M | 7.59M | 14.70M | 13.25M | 8.17M | 2.58M | 3.67M | 40.84K | 92.04K | 84.71K | 153.19K | 478.67K | 151.97K | 61.48K | 32.37K |
| Selling & Marketing | 1.11M | 575.71K | 351.01K | 2.04M | 1.37M | 671.37K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.13M | 7.21M | 7.94M | 16.73M | 14.62M | 8.84M | 2.58M | 3.67M | 40.84K | 92.04K | 84.71K | 153.19K | 478.67K | 151.97K | 61.48K | 32.37K |
| Other Expenses | 0.00 | 193.42K | 298.01K | 185.33K | 0.00 | -565.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -602.76K | 7.71M | 8.44M | 18.92M | 15.27M | 9.12M | 2.60M | 3.67M | 40.84K | 92.04K | 84.97K | 154.21K | 567.78K | 152.18K | 61.48K | 32.37K |
| Cost & Expenses | 27.62M | 17.56M | 15.60M | 28.60M | 28.03M | 15.32M | 3.40M | 3.67M | 40.84K | 92.04K | 84.97K | 154.21K | 567.78K | 152.18K | 61.48K | 32.37K |
| Interest Income | 0.00 | 16.49K | 2.11M | 3.70M | 2.79M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.00 | 409.00 | 0.00 |
| Interest Expense | 1.72M | 1.76M | 2.11M | 3.70M | 2.79M | 842.12K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.69M | 1.92M | 993.31K | 2.19M | 648.97K | 278.61K | 13.53K | 1.70M | 163.37K | -3.50K | 255.00 | 1.02K | 716.00 | 208.00 | 0.00 | 0.00 |
| EBITDA | -10.03M | -2.88M | -2.71M | -14.26M | -9.32M | -2.87M | -2.53M | 0.00 | 0.00 | -95.54K | 860.74K | -95.96K | -567.06K | -151.80K | -61.07K | -29.71K |
| EBITDA Ratio | -54.91% | -23.01% | -19.45% | -120.77% | -51.60% | -23.39% | -228.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87,742.77% | -14,931.78% | -1,119.06% |
| Operating Income | -9.35M | -4.81M | -3.32M | -16.63M | -9.97M | -3.24M | -2.55M | -3.67M | -40.84K | -92.04K | -1.03M | -211.44K | -567.78K | -152.00K | -61.07K | -29.71K |
| Operating Income Ratio | -51.16% | -38.35% | -27.74% | -139.04% | -55.20% | -25.59% | -247.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87,863.01% | -14,931.78% | -1,119.06% |
| Total Other Income/Expenses | -4.09M | -12.71M | -2.48M | -3.51M | -9.68M | -1.96M | -193.25K | 0.00 | 0.00 | 3.50K | 0.00 | 0.00 | 0.00 | 0.00 | 61.07K | 29.71K |
| Income Before Tax | -13.44M | -17.52M | -5.81M | -20.15M | -19.65M | -4.31M | -2.55M | -3.67M | -40.84K | -88.54K | -1.03M | -211.44K | -567.78K | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -73.57% | -139.71% | -48.48% | -168.40% | -108.79% | -34.08% | -247.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 515.53K | 549.00K | 482.00K | -128.05K | -1.11M | 1.18M | 67.08K | -3.67M | -163.37K | 0.00 | 945.46K | -55.54K | -3.62K | 0.00 | 61.07K | 29.71K |
| Net Income | -13.36M | -17.81M | -6.47M | -21.54M | -18.79M | -5.84M | -2.73M | -3.67M | -40.84K | -88.54K | -1.03M | -155.90K | -564.16K | -152.00K | -61.07K | -29.71K |
| Net Income Ratio | -73.13% | -142.02% | -54.03% | -180.08% | -104.03% | -46.20% | -265.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87,863.01% | -14,931.78% | -1,119.06% |
| EPS | -0.03 | -0.04 | -0.02 | -0.08 | -0.07 | -0.03 | -0.06 | -0.21 | -0.01 | -0.05 | -0.67 | -0.12 | -0.47 | -0.29 | -0.61 | -0.58 |
| EPS Diluted | -0.03 | -0.04 | -0.02 | -0.08 | -0.07 | -0.03 | -0.06 | -0.21 | -0.01 | -0.05 | -0.67 | -0.12 | -0.47 | -0.29 | -0.61 | -0.58 |
| Weighted Avg Shares Out | 455.69M | 450.68M | 387.01M | 286.37M | 252.12M | 192.47M | 45.70M | 17.83M | 3.33M | 1.83M | 1.54M | 1.26M | 1.20M | 515.47K | 100.00K | 51.63K |
| Weighted Avg Shares Out (Dil) | 455.69M | 450.68M | 387.01M | 286.37M | 252.12M | 192.47M | 45.70M | 17.83M | 3.33M | 1.83M | 1.54M | 1.26M | 1.20M | 515.47K | 100.00K | 51.63K |
1933 Industries Reports Second Quarter 2021 Financial Results
1933 Industries Announces Extraordinary Meeting of Debentureholders to Extend the Maturity Date of its Convertible Debentures
Source: https://incomestatements.info
Category: Stock Reports